APA (7th ed.) Citation

Alessandro Inno, Giuseppe Bogina, Giulio Settanni, Matteo Salgarello, Giovanni Foti, Carlo Pomari, . . . Stefania Gori. (2023). First-line tepotinib for a very elderly patient with metastatic NSCLC harboring MET exon 14 skipping mutation and high PD-L1 expression. AboutScience Srl.

Chicago Style (17th ed.) Citation

Alessandro Inno, Giuseppe Bogina, Giulio Settanni, Matteo Salgarello, Giovanni Foti, Carlo Pomari, Vincenzo Picece, and Stefania Gori. First-line Tepotinib for a Very Elderly Patient with Metastatic NSCLC Harboring MET Exon 14 Skipping Mutation and High PD-L1 Expression. AboutScience Srl, 2023.

MLA (9th ed.) Citation

Alessandro Inno, et al. First-line Tepotinib for a Very Elderly Patient with Metastatic NSCLC Harboring MET Exon 14 Skipping Mutation and High PD-L1 Expression. AboutScience Srl, 2023.